Updated 02:01 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,868.50 -0.46% CL 85.14 -3.86% BTC 65,305.22 0.00%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,869 −0.46% BTC $65,305 VIX 22.91 +18.70% latest tape · as of 02:01 UTC
The Screen · Basic Materials · Chemicals

BASF SE

BAS.DE · XETRA · EUR · Market cap $43.8B · 106,428 employees

BASF SE operates as a chemical company worldwide.

PASS · Titan Ethical · score 70.0
54.27 EUR

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price54.27 EUR at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readAccumulation, as of 15 Nov 2026
  • Ethical screenPasses, score 70.0 out of 100
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: 36.00 EUR to 44.83 EUR, base estimate 38.98 EUR (screen dated 2026-11-13).

Current read
Accumulation ?
Overvalued · screened 2026-11-13
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price54.27 EUR
Fair value38.98
Ethical score70.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-20Read Accumulation52.46+3.5% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown51.36+5.7% to today Accumulation gives way to Markdown with volume flow in agreement
2026-08-22Read Accumulation49.50+9.6% to today ✓Distribution gives way to Accumulation with volume flow in agreement
2026-07-02Read Distribution49.50+9.6% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

BASF SE holds its Accumulation at $54.27. The statistical read favours the buyers, held for 22 days.

As held on the ledger · 2026-11-13
PhaseAccumulation
Quantitative stateThe statistical read favours the buyers, held for 22 days
Price at the screen$54.27
Valuation30.21 trailing · 17.39 forward price to earnings
Values screenPASS · score 70.0
Beta0.73
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 30.47% Below 33% Interest-bearing debt is just 30.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 3.51% Below 33% Cash held in interest-bearing accounts and securities is 3.5% of assets, under the one-third limit. Pass
Receivables 10.93% Below 49% Money owed to the company is 10.9% of assets, under the 49% limit. Pass
Revenue purity 0.86% Below 5% Only 0.9% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

BASF SE clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when BAS.DE's ethical verdict changes

Today BAS.DE passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our 38.98 EUR fair value estimate.

How a fair value is estimated: discounted cash flow (DCF).

36.00Conservative38.98Base case44.83Growth case 54.27Price

Fair value range in EUR, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 39.2% above the base estimate.

The Street's Range
40.00Street low 53.00Street average 63.00Street high 54.27Price

Third-party analyst targets: 21 covering, consensus Buy. The average target sits −2% from the screen price.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections

Where our models see it going: fair-value estimate 38.98 EUR, with a range of 36.00 EUR to 44.83 EUR, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 17.4x forward earnings, the price already runs ahead of the business. It trades 39% above our 38.98 EUR fair value, so you would be buying at a premium, not a discount.

The fundamentals · plain-English read
Forward P/E17.4xreasonably valued
Trailing P/E30.2xa premium valuation
EPS, trailing1.70
EPS, forward2.95
Revenue growth-3.0%revenue is shrinking
Profit margin2.9%barely profitable
Return on equity4.4%a modest return on shareholder capital
FCF yield-3.44%
Dividend yield4.35%
Debt to equity0.67moderate, manageable leverage
Beta0.73steadier than the market
52-week range40.97 - 55.05
Market cap$43.8B
Employees106,428

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: its business and earnings are exposed to Germany and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

BAS.DE trades on XETRA (the company is based in Germany). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-12 Accumulation $54.48 +1.9% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-11-01 Accumulation $53.46 +1.9% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-10-20 Accumulation · changed $52.46 +1.5% Entry 8

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-10-13 Markdown $51.68 +0.6% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-10-02 Markdown · changed $51.36 +3.8% Entry 6

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-08-22 Accumulation · changed $49.50 +0.0% Entry 5

The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-07-22 Distribution $49.50 +0.0% Entry 4

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-07-18 Distribution $49.50 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (21 analysts) rates it buy, with a mean price target of $53.

2026-07-03 Distribution $49.50 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Distribution $49.50 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $53.46 -10.3% · $898 -10.3%
2 months $52.45 -8.5% $2.25 $958 -4.2%
3 months $44.41 +8.1% $2.25 $1,131 +13.1%
6 months $42.73 +12.3% $2.25 $1,176 +17.6%
1 year $41.70 +15.1% $2.25 $1,204 +20.4%
2 years $42.01 +14.2% $4.50 $1,249 +24.9%
3 years $39.10 +22.7% $7.90 $1,429 +42.9%
5 years $49.70 -3.5% $14.70 $1,261 +26.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever BAS.DE does next, these words stay.

BASF SE · BAS.DE · Accumulation · $54.27
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.